Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

The Food and Drug Administration (FDA) has authorized the emergency use of the Novavax COVID-19 Vaccine, Adjuvanted.

While Australia's therapeutic goods regulator is evaluating two new vaccines targeting the JN.1 strain of COVID-19, the ...

The Novavax vaccine, which Pavia said is a protein vaccine rather than ... but only 15.9% received the bivalent booster. The ...

Novavax has updated its protein subunit vaccine to target XBB.1.5 as well ... Disease Organization at the University of ...

But it's not to go sightseeing or shopping. Wilhelm, who suffers from severe rheumatoid arthritis, hopes to get the updated Novavax COVID-19 vaccine, which won't be available in Canada as part of ...

Novavax (NVX-CoV2373) is a vaccine used to reduce the risk of serious infection from the virus that causes COVID-19. Novavax can cause side effects that range from mild to serious. Examples ...

Struggling biotech Novavax (NASDAQ: NVAX) was a hot buy a few years ago as it was in the midst of developing a vaccine for COVID-19. Ultimately, it did produce an approved vaccine, but it was a ...

one dose of Novavax COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) is administered at least 2 months after receipt of the last previous dose of an original monovalent (Original) or bivalent ...

Here's what to know about the latest vaccines, who needs them and how they ... authorization last week to an updated version of the Novavax shot, which includes a "monovalent (single) component ...

Here's what to know about the latest vaccines, who needs them and how they help prevent the more serious effects of COVID-19. The FDA granted emergency use authorization last week to an updated ...